GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is ...

Haleon has gained full control of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da Ren Tang's 12% stake.

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver ...

With rising global demand for more personalised and effective healthcare solutions, the Department of Health - Abu Dhabi (DoH ...

The UK’s two biggest drug makers, AstraZeneca and GlaxoSmithKline, have some manufacturing bases in the US, which could help them dodge the levies to some extent. UK-based GlaxoSmithKline ...

Shares of GSK PLC GSK slipped 6.07% to £13.32 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 4.38% to 7,702.08. GSK PLC ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc (“GSK” or “the Company”) (NYSE: GSK) for violations of ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. ABL Bio has ...